Clinical Trial Update: LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 proof-of-concept trial evaluating LUXSOL Topical Cream for symptomatic bacterial vaginosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• LUXSOL Topical Cream

Snippet

Sponsor: CDA Research Group, Inc. | Conditions: Bacterial Vaginosis (BV) | EARLY_Phase 1 | Status: TERMINATED